FRMD4B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.456000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.090200E-02
Normal-vs-Stage2
1.031790E-01
Normal-vs-Stage3
1.235820E-02
Normal-vs-Stage4
4.995200E-01
Stage1-vs-Stage2
5.376800E-01
Stage1-vs-Stage3
4.604600E-01
Stage1-vs-Stage4
2.718600E-01
Stage2-vs-Stage3
2.214600E-01
Stage2-vs-Stage4
3.781800E-01
Stage3-vs-Stage4
9.068000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.536400E-02
Normal-vs-AfricanAmerican
5.135000E-01
Normal-vs-Asian
5.627600E-01
Caucasian-vs-AfricanAmerican
5.888200E-01
Caucasian-vs-Asian
2.342200E-01
AfricanAmerican-vs-Asian
8.243600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.425600E-02
Normal-vs-Female
8.313600E-02
Male-vs-Female
7.499000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.365700E-02
Normal-vs-Age(41-60Yrs)
3.432400E-01
Normal-vs-Age(61-80Yrs)
1.899560E-02
Normal-vs-Age(81-100Yrs)
8.015800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.401000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.818000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.655800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.258100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.680700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.813200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.221600E-01
Normal-vs-Daily Drinker
4.777900E-02
Normal-vs-Weekly Drinker
1.364230E-02
Normal-vs-Occasional Drinker
1.211590E-01
Normal-vs-Social Drinker
5.016000E-02
Non Drinker-vs-Daily Drinker
4.073600E-01
Non Drinker-vs-Weekly Drinker
2.300600E-01
Non Drinker-vs-Occasional Drinker
9.654400E-01
Non Drinker-vs-Social Drinker
6.437800E-01
Daily Drinker-vs-Weekly Drinker
6.444200E-01
Daily Drinker-vs-Occasional Drinker
4.782000E-01
Daily Drinker-vs-Social Drinker
7.660600E-01
Weekly Drinker-vs-Occasional Drinker
2.685800E-01
Weekly Drinker-vs-Social Drinker
4.443400E-01
Occasional Drinker-vs-Social Drinker
6.924000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.319400E-01
Normal-vs-Grade 2
5.747900E-02
Normal-vs-Grade 3
4.031800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.601700E-02
Grade 1-vs-Grade 3
7.686300E-02
Grade 1-vs-Grade 4
2.319400E-01
Grade 2-vs-Grade 3
7.673600E-01
Grade 2-vs-Grade 4
5.747900E-02
Grade 3-vs-Grade 4
4.031800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.915800E-02
Normal-vs-NonDiabetic
5.155700E-02
Diabetic-vs-NonDiabetic
7.846600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.753000E-01
Normal-vs-NoPancreatitis
2.285500E-02
Pancreatitis-vs-NoPancreatitis
2.683400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.688100E-02
Normal-vs-N1
8.736000E-02
N0-vs-N1
1.609750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.745450E-01
Normal-vs-TP53-NonMutant
8.529700E-02
TP53-Mutant-vs-TP53-NonMutant
1.297210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
